Toll-Like Receptor 4 (TLR4)

Toll-Like Receptor 4 (TLR4)

<div class="infobox" style="float:right; width:280px; padding:10px; border:1px solid #ddd; margin:0 0 10px 10px; background:#f9f9f9;">
<h3 style="margin-top:0; border-bottom:1px solid #ccc;">TLR4</h3>
<table style="width:100%; font-size:0.9em;">
<tr><td><b>Gene</b></td><td>[TLR4](/genes/tlr4)</td></tr>
<tr><td><b>UniProt</b></td><td>[O00206](https://www.uniprot.org/uniprot/O00206)</td></tr>
<tr><td><b>MW</b></td><td>95 kDa</td></tr>
<tr><td><b>Location</b></td><td>Cell membrane, endosomes</td></tr>
<tr><td><b>PDB</b></td><td>[3FXI](https://www.rcsb.org/structure/3FXI)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-f3fb3b91" style="color:#ce93d8" title="Score: 0.71">Selective TLR4 Modulation to Prevent Gut...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1290 edges</a></td>
</tr>
</table>
</div>

Pathway Diagram

Toll-Like Receptor 4 (TLR4)

<div class="infobox" style="float:right; width:280px; padding:10px; border:1px solid #ddd; margin:0 0 10px 10px; background:#f9f9f9;">
<h3 style="margin-top:0; border-bottom:1px solid #ccc;">TLR4</h3>
<table style="width:100%; font-size:0.9em;">
<tr><td><b>Gene</b></td><td>[TLR4](/genes/tlr4)</td></tr>
<tr><td><b>UniProt</b></td><td>[O00206](https://www.uniprot.org/uniprot/O00206)</td></tr>
<tr><td><b>MW</b></td><td>95 kDa</td></tr>
<tr><td><b>Location</b></td><td>Cell membrane, endosomes</td></tr>
<tr><td><b>PDB</b></td><td>[3FXI](https://www.rcsb.org/structure/3FXI)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-f3fb3b91" style="color:#ce93d8" title="Score: 0.71">Selective TLR4 Modulation to Prevent Gut...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1290 edges</a></td>
</tr>
</table>
</div>

Pathway Diagram

Overview

Toll-like receptor 4 (TLR4) is a pattern recognition receptor that serves as the primary sensor for bacterial lipopolysaccharide (LPS). Expressed on [microglia](/cell-types/microglia-neuroinflammation), [astrocytes](/entities/astrocytes), and peripheral immune cells, [TLR4](/entities/tlr4) triggers innate immune responses through MyD88-dependent and TRIF-dependent signaling pathways. In the CNS, TLR4 mediates neuroinflammation and has been implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions.

Structure and Domains

TLR4 is a type I transmembrane receptor with:

• Leucine-rich repeats (LRR): 22 extracellular LRRs form the ligand-binding ectodomain
• Ectodomain: Horseshoe-shaped structure for LPS and DAMP recognition
• Transmembrane domain: Single-pass membrane anchor
• TIR domain: C-terminal cytoplasmic domain for adaptor recruitment

MD-2 Association

TLR4 forms a complex with MD-2 (LY96) at the cell surface:

• MD-2 binds directly to the hydrophobic portion of LPS
• The TLR4-MD-2 complex dimerizes upon LPS binding
• Dimerization brings TIR domains together for downstream signaling

Normal Function

LPS Recognition

TLR4 detects gram-negative bacterial infections:

Signaling Pathways

TLR4 activates two distinct pathways:

| Pathway | Adaptor | Outcome |
|---------|---------|---------|
| MyD88-dependent | MyD88, TIRAP | Early [NF-κB](/entities/nf-kb) activation, pro-inflammatory cytokines |
| TRIF-dependent | TRIF, TRAM | Late NF-κB, IRF3 activation, type I interferons |

Role in Neurodegeneration

Alzheimer's Disease

TLR4 contributes to AD pathogenesis through multiple mechanisms:

• [Aβ](/proteins/amyloid-beta) recognition: TLR4 can bind amyloid-β and trigger microglial activation[@fassbender2004]
• Neuroinflammation: TLR4 activation sustains chronic inflammation in AD brain
• DAMP sensing: HMGB1 and other DAMPs from dying [neurons](/entities/neurons) activate TLR4
• [Blood-brain barrier](/entities/blood-brain-barrier): LPS leakage across compromised BBB activates TLR4

Parkinson's Disease

TLR4 is implicated in dopaminergic neuron degeneration:

• [α-synuclein](/proteins/alpha-synuclein) sensing: Aggregated α-synuclein can activate TLR4 on microglia[@kim2011]
• [Gut-brain axis](/entities/gut-brain-axis): Intestinal LPS reaches the brain via vagus nerve
• Neuroinflammation: TLR4-driven inflammation contributes to nigral degeneration
• MPTP models: TLR4 knockout mice are partially protected from MPTP toxicity

Amyotrophic Lateral Sclerosis

TLR4 expression is elevated in ALS:

• Microglial activation: TLR4 contributes to microglial reactivity in ALS spinal cord
• [TDP-43](/mechanisms/tdp-43-proteinopathy): Cytoplasmic TDP-43 aggregates may activate TLR4
• Disease progression: TLR4 levels correlate with disease severity

Traumatic Brain Injury

TLR4 mediates post-traumatic neuroinflammation:

• DAMP release: HMGB1 and HSPs released after injury activate TLR4
• Blood-brain barrier breakdown: Allows peripheral LPS entry
• Chronic inflammation: Persistent TLR4 activation may link TBI to later neurodegeneration

Therapeutic Targeting

TLR4 Antagonists

Several strategies target TLR4 in neurodegeneration:

| Agent | Mechanism | Status |
|-------|-----------|--------|
| TAK-242 (Resatorvid) | Binds TIR domain, blocks signaling | Preclinical/clinical trials |
| Eritoran | MD-2 antagonist, prevents LPS binding | Phase III (sepsis), preclinical (neuro) |
| E5564 | Synthetic lipid A analogue | Clinical development |
| Natural antagonists | Curcumin, resveratrol | Dietary supplements |

Anti-Inflammatory Combinations

TLR4 inhibition may synergize with other approaches:

• [NLRP3](/entities/nlrp3-inflammasome) inhibitors: Dual targeting of innate immune pathways
• NSAIDs: Combine with TLR4 blockade for enhanced anti-inflammatory effect
• [Microbiome](/entities/microbiome) modulation: Reduce systemic LPS burden

Key Interactions

| Partner | Function | Disease Relevance |
|---------|----------|-------------------|
| MD-2 (LY96) | LPS co-receptor | Required for signaling |
| CD14 | LPS presentation | Enhances sensitivity |
| MyD88 | Signal adaptor | NF-κB activation |
| TRIF | Signal adaptor | IRF3/interferon |
| HMGB1 | Endogenous DAMP | Neurodegeneration |
| α-synuclein | Protein aggregate | PD neuroinflammation |

Genetic Polymorphisms

TLR4 polymorphisms influence neurodegenerative disease risk:

• Asp299Gly (rs4986790): Reduced LPS responsiveness
• Thr399Ile (rs4986791): Altered signaling
• AD association: Some studies suggest modified AD risk with TLR4 variants[@balistreri2013]

Key Publications

See Also

• [TLR4 Gene](/genes/tlr4)
• [TDP-43](/mechanisms/tdp-43-proteinopathy)

External Links

• [UniProt: O00206](https://www.uniprot.org/uniprot/O00206)
• [PDB structures](https://www.rcsb.org/search?q=uniprot:O00206)
• [GeneCards: TLR4](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TLR4)

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Enteric Nervous System Prion-Like Propagation Blockade](/hypothesis/h-2e7eb2ea) — <span style="color:#ffd54f;font-weight:600">0.42</span> · Target: TLR4, SNCA

Pathway Diagram

The following diagram shows the key molecular relationships involving Toll-Like Receptor 4 (TLR4) discovered through SciDEX knowledge graph analysis: